{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:32:15Z","timestamp":1790487135483,"version":"4.1.0"},"reference-count":73,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1253\/circj.cj-08-1071","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T05:56:58Z","timestamp":1232690218000},"page":"214-220","source":"Crossref","is-referenced-by-count":71,"title":["Peroxisome Proliferator-Activated Receptor .GAMMA. and Cardiovascular Diseases"],"prefix":"10.1253","volume":"73","author":[{"given":"Hiroyuki","family":"Takano","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645-650.","DOI":"10.1038\/347645a0"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/34184"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1038\/34178"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Marx N, Schonbeck U, Lazar MA, Libby P, Plutzky J. Peroxisome proliferator-activated receptor γ activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res 1998; 83: 1097-1103.","DOI":"10.1161\/01.RES.83.11.1097"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8794"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Benson S, Wu J, Padmanabhan S, Kurtz TW, Pershadsingh HA. Peroxisome proliferator-activated receptor (PPAR)-γ expression in human vascular smooth muscle cells: Inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-γ activator troglitazone. Am J Hypertens 2000; 13: 74-82.","DOI":"10.1016\/S0895-7061(99)00148-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takano H, Nagai T, Asakawa M, Toyozaki T, Oka T, Komuro I, et al. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-α expression in neonatal rat cardiac myocytes. Circ Res 2000; 87: 596-602.","DOI":"10.1161\/01.RES.87.7.596"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Marx N, Sukhova G, Murphy C, Libby P, Plutzky J. Macrophage in human atheroma contain PPARγ: Differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. Am J Pathol 1998; 153: 17-23.","DOI":"10.1016\/S0002-9440(10)65540-X"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7614"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rhee EJ, Kwon CH, Lee WY, Kim SY, Jung CH, Kim BJ, et al. No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects. Circ J 2007; 71: 338-342.","DOI":"10.1253\/circj.71.338"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.551"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(04)00133-3"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0405786101"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1038\/nature03988"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81574-3"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81575-5"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1038\/22572"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000014225.20727.8F"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bouhlel MA, Derudas B, Rigamonti E, Dièvart R, Brozek J, Haulon S, et al. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007; 6: 137-143.","DOI":"10.1016\/j.cmet.2007.06.010"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1038\/nature05894"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118991"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199905000-00018"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.2.392"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011655200"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00758-5"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Aizawa Y, Kawabe J, Hasebe N, Takehara N, Kikuchi K. Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia. Circulation 2001; 104: 455-460.","DOI":"10.1161\/hc3001.092040"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1210\/en.142.7.3125"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Takeda K, Ichiki T, Tokunou T, Funakoshi Y, Iino N, Hirano K, et al. Peroxisome proliferator-activated receptor γ activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. Circulation 2000; 102: 1834-1839.","DOI":"10.1161\/01.CIR.102.15.1834"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Tham DM, Martin-McNulty B, Wang YX, Wilson DW, Vergona R, Sullivan ME, et al. Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs. Physiol Genomics 2002; 11: 21-30.","DOI":"10.1152\/physiolgenomics.00062.2002"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Jackson SM, Parhami F, Xi XP, Berliner JA, Hsueh WA, Law RE, et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol 1999; 19: 2094-2104.","DOI":"10.1161\/01.ATV.19.9.2094"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Pasceri V, Wu HD, Willerson JT, Yeh ETH. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators. Circulation 2000; 101: 235-238.","DOI":"10.1161\/01.CIR.101.3.235"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, et al. Role of peroxisome proliferator-activated receptor α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 2000; 87: 516-521.","DOI":"10.1161\/01.RES.87.6.516"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00461-1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, et al. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 1999; 85: 394-402.","DOI":"10.1161\/01.RES.85.5.394"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.2.1241"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000; 289: 1524-1529.","DOI":"10.1126\/science.289.5484.1524"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.200367697"},{"issue":"36","key":"38","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1074\/jbc.M003337200","volume":"275","author":"COSTET P","year":"2000","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00164-2"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 2001; 7: 53-58.","DOI":"10.1038\/83348"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000016049.86468.23"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000047447.67827.CD"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Marx N, Imhof A, Froehlich J, Siam L, Ittner J, Wierse G, et al. Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease. Circulation 2003; 107: 1954-1957.","DOI":"10.1161\/01.CIR.0000069272.06194.91"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Mehrabi MR, Thalhammer T, Haslmayer P, Glogar HD, Wieselthaler G, Humpeler S, et al. The peroxisome proliferator-activated receptor γ (PPARγ) is highly expressed in human heart ventricles. Biomed Pharmacother 2002; 56: 407-410.","DOI":"10.1016\/S0753-3322(02)00251-2"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Yue T, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, et al. In vivo myocardial protection from IR injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 2001; 104: 2588-2594.","DOI":"10.1161\/hc4601.099403"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.5.1507"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0793com"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Zhu P, Lu L, Xu Y, Schwartz GG. Troglitazone improves recovery of left ventricular function after regional ischemia in pigs. Circulation 2000; 101: 1165-1171.","DOI":"10.1161\/01.CIR.101.10.1165"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000039346.31538.2C"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Ikejima H, Imanishi T, Tsujioka H, Kuroi A, Muragaki Y, Mochizuki S, et al. Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor. Circ J 2008; 72: 998-1002.","DOI":"10.1253\/circj.72.998"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.491"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1161\/hc4001.097186"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1161\/hc1002.105225"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000179226.34112.6d"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Ding G, Fu M, Qin Q, Lewis W, Kim HW, Fukai T, et al. Cardiac peroxisome proliferator-activated receptor γ is essential in protecting cardiomyocytes from oxidative damage. Cardiovasc Res 2007; 76: 269-279.","DOI":"10.1016\/j.cardiores.2007.06.027"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Son NH, Park TS, Yamashita H, Yokoyama M, Huggins LA, Okajima K, et al. Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in mice. J Clin Invest 2007; 117: 2791-2801.","DOI":"10.1172\/JCI30335"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Toyozaki T, Saito T, Shiraishi H, Tsukamoto Y, Takano H, Nagai T, et al. Macrophage inflammatory protein-1α relates to the recruitment of inflammatory cells in myosin-induced autoimmune myocarditis in rats. Lab Invest 2001; 81: 929-936.","DOI":"10.1038\/labinvest.3780303"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Wang Y, et al. Peroxisome proliferation-activated receptor-γ ligands ameliorate experimental autoimmune myocarditis. Cardiovasc Res 2003; 59: 685-694.","DOI":"10.1016\/S0008-6363(03)00457-7"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Hasegawa H, Takano H, Zou Y, Qin Y, Hizukuri K, Odaka K, et al. Pioglitazone, a peroxisome proliferator-activated receptor γ activator, ameliorates experimental autoimmune myocarditis by modulating Th1\/Th2 balance. J Mol Cell Cardiol 2005; 38: 257-265.","DOI":"10.1016\/j.yjmcc.2004.11.010"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000054675.30348.9A"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Sotiropoulos KB, Clermont A, Yasuda Y, Rask-Madsen C, Mastumoto M, Takahashi J, et al. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: Novel mechanism for PPARγ agonist's effects on edema and weight gain. FASEB J 2006; 20: 1203-1205.","DOI":"10.1096\/fj.05-4617fje"},{"key":"62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0501744102"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, et al. Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption. Nat Med 2005; 11: 861-866.","DOI":"10.1038\/nm1278"},{"key":"64","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.11.2058"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00159-1"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072761"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: A meta-analysis. JAMA 2007; 298: 1189-1195.","DOI":"10.1001\/jama.298.10.1189"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care 2005; 28: 1547-1554.","DOI":"10.2337\/diacare.28.7.1547"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Orasanu G, Ziouzenkova O, Devchand PR, Nehra V, Hamdy O, Horton ES, et al. The peroxisome proliferator-activated receptor-γ agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-α-dependent manner in vitro and in vivo in mice. J Am Coll Cardiol 2008; 52: 869-881.","DOI":"10.1016\/j.jacc.2008.04.055"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Werner C, Kamani CH, Gensch C, Böhm M, Laufs U. The peroxisome proliferator-activated receptor-γ agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 2007; 56: 2609-2615.","DOI":"10.2337\/db07-0069"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000103683.99399.7E"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, et al. Statins activate peroxisome proliferator-activated receptor γ through extracellular signal-regulated kinase 1\/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 2007; 100: 1442-1451.","DOI":"10.1161\/01.RES.0000268411.49545.9c"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/2\/73_CJ-08-1071\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T12:42:24Z","timestamp":1633005744000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/2\/73_CJ-08-1071\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-08-1071","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}